''The reality is we will have to wait until the later part of 2020 to confirm any meaningful results from the Phase 2 study. What would happens to Novogen share price in the meantime? Remain the same or decrease? What is the deal with Genetech if the study is successful? How much would Novogen get? Where is the funding coming from? It's OK to wait if I am employed full time and paid in full by Novogen. But as an investor, I doubt it!''
Steelcouch , fair questions imo hence no real buyer support today
You cant expect the market to sustain a share price increase for something expected in 2020-2021 without any other details like you mention
IMO,
With the current sentiment and share price any further dilution would not benefit current shareholders
